T

TROIANI T.

Last name: TROIANI T.

2023 (v1)

Publication

Metadata-only

Characteristics of Real-World Patients with High-Risk BRAFV600E/K-Mutated Melanoma Receiving Adjuvant Treatment with Dabrafenib Plus Trametinib After Surgical Resection, Through the Italian Managed Access Program

Quaglino P. Ascierto P. A. Consoli F.

Purpose: Real-world data from patients with BRAFV600-mutated, resected, stage III melanoma treated with dabrafenib plus trametinib as adjuvant targeted therapy are limited, and it is important to gain an understanding of the characteristics of this patient population, as well as of the patient journey. Here we aimed to describe the...

Uploaded on: July 3, 2024
2023 (v1)

Publication

Metadata-only

Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profile

Ascierto P. A. Di Giacomo A. M. Chiarion Sileni V.

Introduction: The CheckMate 238 randomised study demonstrated the relevant benefit in terms of recurrence-free survival (RFS) of nivolumab versus ipilimumab in resected stage IIIB-C or IV melanoma patients with a tolerable safety profile. Materials and methods: From November 2018 to June 2019, 611 patients with stage III and IV resected...

Uploaded on: July 3, 2024
2021 (v1)

Publication

Metadata-only

Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma

Baggi A. Quaglino P. Rubatto M.

No description

Uploaded on: July 3, 2024